Saket Srivastava
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Dual targeting of CD19 and CD22 against B-ALL using a novel high-sensitivity aCD22 CAR.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: December 16, 2023
Exploration of T cell immune responses by expression of a dominant-negative SHP1 and SHP2.
Journal: Frontiers in immunology
Published: December 08, 2022
Dual targeting of CD19 and CD22 against B-ALL using a novel high-sensitivity aCD22 CAR.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: September 03, 2022
Enhancing CAR T-cell Therapy Using Fab-Based Constitutively Heterodimeric Cytokine Receptors.
Journal: Cancer immunology research
Published: August 10, 2022
Efficient clinical-grade γ-retroviral vector purification by high-speed centrifugation for CAR T cell manufacturing.
Journal: Molecular therapy. Methods & clinical development
Published: June 19, 2022
Structure-guided engineering of immunotherapies targeting TRBC1 and TRBC2 in T cell malignancies.
Journal: Nature communications
Published: March 21, 2022
CAR T cells with dual targeting of CD19 and CD22 in pediatric and young adult patients with relapsed or refractory B cell acute lymphoblastic leukemia: a phase 1 trial.
Journal: Nature medicine
Published: March 19, 2021
Showing 1-8 of 8
Last Updated: 09/26/2026